{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["21(16)"],"submitter":["Sixto-Lopez Y"],"pubmed_abstract":["N-(2'-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA) is a VPA derivative designed to be a histone deacetylase (HDAC) inhibitor. HO-AAVPA has better antiproliferative effect than VPA in cancer cell lines. Therefore, in this work, the inhibitory effect of HO-AAVPA on HDAC1, HDAC6, and HDAC8 was determined by in silico and in vitro enzymatic assay. Furthermore, its antiproliferative effect on the cervical cancer cell line (SiHa) and the translocation of HMGB1 and ROS production were evaluated. The results showed that HO-AAVPA inhibits HDAC1, which could be related with HMGB1 translocation from the nucleus to the cytoplasm due to HDAC1 being involved in the deacetylation of HMGB1. Furthermore, an increase in ROS production was observed after the treatment with HO-AAVPA, which also could contrib"],"journal":["International journal of molecular sciences"],"pagination":["E5873"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7461584"],"repository":["biostudies-literature"],"pubmed_title":["N-(2'-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Inhibits HDAC1 and Increases the Translocation of HMGB1 Levels in Human Cervical Cancer Cells."],"pmcid":["PMC7461584"],"pubmed_authors":["Mendieta-Wejebe JE","Rosales-Hernandez MC","Correa-Basurto AM","Sixto-Lopez Y","Contis-Montes de Oca A","Correa-Basurto J","Abarca-Rojano E","Fragoso-Morales LG"],"additional_accession":[]},"is_claimable":false,"name":"N-(2'-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Inhibits HDAC1 and Increases the Translocation of HMGB1 Levels in Human Cervical Cancer Cells.","description":"N-(2'-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA) is a VPA derivative designed to be a histone deacetylase (HDAC) inhibitor. HO-AAVPA has better antiproliferative effect than VPA in cancer cell lines. Therefore, in this work, the inhibitory effect of HO-AAVPA on HDAC1, HDAC6, and HDAC8 was determined by in silico and in vitro enzymatic assay. Furthermore, its antiproliferative effect on the cervical cancer cell line (SiHa) and the translocation of HMGB1 and ROS production were evaluated. The results showed that HO-AAVPA inhibits HDAC1, which could be related with HMGB1 translocation from the nucleus to the cytoplasm due to HDAC1 being involved in the deacetylation of HMGB1. Furthermore, an increase in ROS production was observed after the treatment with HO-AAVPA, which also could contrib","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Aug","modification":"2025-04-21T14:16:51.933Z","creation":"2020-09-09T07:07:20Z"},"accession":"S-EPMC7461584","cross_references":{"pubmed":["32824279"],"doi":["10.3390/ijms21165873"]}}